How to cite this paper
Kumar, H., Acharyya, S., Mondal, P., Patra, P & Sahu, S. (2023). Quantification of Alectinib in spiked rabbit plasma using liquid chromatography- electro spray ionization-tandem mass spectrophotometry: An application to pharmacokinetic study.Current Chemistry Letters, 12(2), 265-274.
Refrences
1. Collins LG, Haines C, Perkel R, Enck R E.(2007) Lung cancer: diagnosis and management. Am Fam Physician, 75(1),56-63.
2. Kinoshita, K., Asoh, K., Furuichi, N., Ito, T., Kawada, H., Hara, S., ... & Oikawa, N. (2012). Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). Bioorganic & medicinal chemistry, 20(3), 1271-1280.
3. Karachaliou N, Bruno MF, Bracht JWP, Rosell R(2019). Profile of alectinib for the treatment of alk-positive non-small cell lung cancer (NSCLC), patient selection and perspectives. Onco targets ther. 12(2), 4567–4575.
4. Gainor JF (2016), Alectinib—A new chapter in the management of alk-positive lung cancer. Transl Lung Cancer Res. 5(3), 343–346.
5. Szymanska UA, Kurzyna M, Segiet-Swięcicka A, Kułak P, Kosior DA (2022), Real-life trends of anticoagulant prescribing practices for pulmonary embolism – results of a single-center study based on the experience of a multi-profile clinical hospital, Sci Rad, 1(1), 36-45.
6. Pavani B, Mounica P, (2019), RP-HPLC method development and validation for estimation of Alectinib in bulk and pharmaceutical dosage form. Int J Pharm and anal Res. 8(3) 293-300.
7. Prashanthi Y, Rao TN, Srinivas Y(2018). Method Development and Validation of Alectinib Drug by RP-HPLC in Bulk and Pharmaceutical Dosage Form. Asian J Pharm anal, 8(4) 186-190.
8. Sundeep HK, Sahu SK, Debata J, (2020). A Novel Ultra Performance Liquid Chromatography-PDA Method Development and Validation for Alectinib in Bulk and its Application to Tablet Dosage Form. Int J Pharm. Investing, 10(4), 537-541.
9. Heinig K, Miya K, Kamei T, Guerini E, Fraier D, Yu L, et al.(2016) Bioanalysis of alectinib and metabolite M4 in human plasma, cross-validation and impact on PK assessment. J Pharm and biomed anal, 161(3) 136-143.
10. Huang XX, Li YX, Li XY, Hu XX, Tang PF, Hu GX, (2017), An UPLC-MS/MS method for the quantitation of alectinib in rat plasma. J Pharm and biomed anal. 132(4) 227-231.
11. Souverain S, Rudaz S, Veuthey JL,(2004) Protein precipitation for the analysis of a drug cocktail in plasma by LC–ESI–MS. J Pharm and Biomd Analysis, 35(4), 913-920,
12. Mondal P, Satla S, Raparla R, (2017) A Novel Simultaneous Quantification Method for Escitalopram and Etizolam in Human Plasma Using Liquid Chromatography-ESI-Tandem Mass Spectrophotometry-Application to Pharmacokinetic Study, Curr Pharm Anal, 13(3), 279-288.
13. Mondal P, Satla S, Raparla R, (2016) Quantification of Blonanserin in Human Plasma Using Liquid Chromatography- Electrospray Ionization-Tandem Mass Spectrophotometry-Application to Pharmacokinetic Study, J Young Pharm, 8(4), 406-414,
14. US Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation. (2013) http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368107.pdf. [Accessed 08 July 2022].
15. US-FDA guidelines for equivalent dose calculation (2022) http://www.fda.gov/downloads/Drugs/.../Guidances/UCM078932.pdf. [Accessed 15 Jun 2022].
16. Zhang Y, Huo M, Zhou. J. Xie S.(2010) PK Solver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comp Meth and Program in Biomed, 99(3),306-14
2. Kinoshita, K., Asoh, K., Furuichi, N., Ito, T., Kawada, H., Hara, S., ... & Oikawa, N. (2012). Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). Bioorganic & medicinal chemistry, 20(3), 1271-1280.
3. Karachaliou N, Bruno MF, Bracht JWP, Rosell R(2019). Profile of alectinib for the treatment of alk-positive non-small cell lung cancer (NSCLC), patient selection and perspectives. Onco targets ther. 12(2), 4567–4575.
4. Gainor JF (2016), Alectinib—A new chapter in the management of alk-positive lung cancer. Transl Lung Cancer Res. 5(3), 343–346.
5. Szymanska UA, Kurzyna M, Segiet-Swięcicka A, Kułak P, Kosior DA (2022), Real-life trends of anticoagulant prescribing practices for pulmonary embolism – results of a single-center study based on the experience of a multi-profile clinical hospital, Sci Rad, 1(1), 36-45.
6. Pavani B, Mounica P, (2019), RP-HPLC method development and validation for estimation of Alectinib in bulk and pharmaceutical dosage form. Int J Pharm and anal Res. 8(3) 293-300.
7. Prashanthi Y, Rao TN, Srinivas Y(2018). Method Development and Validation of Alectinib Drug by RP-HPLC in Bulk and Pharmaceutical Dosage Form. Asian J Pharm anal, 8(4) 186-190.
8. Sundeep HK, Sahu SK, Debata J, (2020). A Novel Ultra Performance Liquid Chromatography-PDA Method Development and Validation for Alectinib in Bulk and its Application to Tablet Dosage Form. Int J Pharm. Investing, 10(4), 537-541.
9. Heinig K, Miya K, Kamei T, Guerini E, Fraier D, Yu L, et al.(2016) Bioanalysis of alectinib and metabolite M4 in human plasma, cross-validation and impact on PK assessment. J Pharm and biomed anal, 161(3) 136-143.
10. Huang XX, Li YX, Li XY, Hu XX, Tang PF, Hu GX, (2017), An UPLC-MS/MS method for the quantitation of alectinib in rat plasma. J Pharm and biomed anal. 132(4) 227-231.
11. Souverain S, Rudaz S, Veuthey JL,(2004) Protein precipitation for the analysis of a drug cocktail in plasma by LC–ESI–MS. J Pharm and Biomd Analysis, 35(4), 913-920,
12. Mondal P, Satla S, Raparla R, (2017) A Novel Simultaneous Quantification Method for Escitalopram and Etizolam in Human Plasma Using Liquid Chromatography-ESI-Tandem Mass Spectrophotometry-Application to Pharmacokinetic Study, Curr Pharm Anal, 13(3), 279-288.
13. Mondal P, Satla S, Raparla R, (2016) Quantification of Blonanserin in Human Plasma Using Liquid Chromatography- Electrospray Ionization-Tandem Mass Spectrophotometry-Application to Pharmacokinetic Study, J Young Pharm, 8(4), 406-414,
14. US Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation. (2013) http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368107.pdf. [Accessed 08 July 2022].
15. US-FDA guidelines for equivalent dose calculation (2022) http://www.fda.gov/downloads/Drugs/.../Guidances/UCM078932.pdf. [Accessed 15 Jun 2022].
16. Zhang Y, Huo M, Zhou. J. Xie S.(2010) PK Solver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comp Meth and Program in Biomed, 99(3),306-14